FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977393182> ?p ?o ?g. }

• W1977393182 endingPage "60" @default.
• W1977393182 startingPage "52" @default.
• W1977393182 abstract "To the authors' knowledge, the natural history of myelosuppression and infectious complications associated with the use of standard cytarabine (ARA-C) plus daunorubicin (7 + 3) remission-induction therapy for adult acute myeloid leukemia (AML) and high dose ARA-C (HDARA-C) consolidation has not been described completely.A retrospective study of untreated adult AML patients receiving standard 7 + 3 induction followed by 5 + 2 and HDARA-C consolidation was undertaken to describe the relationship of the myelosuppression profiles, blood product use, and infectious morbidity, and to correlate this finding with the outcome of antileukemic therapy. Multivariate techniques were used to evaluate variables of prognostic importance.Fifty-nine percent of the patients achieved remission after a median of 35 days; almost half (48%) of these patients required more than one 7 + 3 induction course. For one, two, and three induction courses, the mean number of days the patients experienced severe neutropenia (< 0.5 x 10(9)/l) were 22.5 +/- 10.9, 39.3 +/- 14.3, and 47.4 +/- 9.7 days (P < 0.001), respectively, and the infection rates were 1.45, 2.45, and 3 infections per course (P < 0.0001), respectively. The pattern of blood product use was similar. HDARA-C consolidation was the most significant factor related to prolonged disease free survival, however the myelosuppression profiles and infection rates were surprisingly similar to those for the single 7 + 3 induction courses.The 7 + 3 induction regimen used in this center provided only limited antileukemic activity, while requiring multiple induction courses in a high proportion of patients. The use of multiple induction courses had consequences of prolonged myelosuppression, increased blood product use, and incremental risks of infectious complications. HDARA-C consolidation for those who experienced complete remission appeared to improve disease free survival with myelosuppression comparable with that of patients who received primary induction therapy. The infection risk was acceptable, with only a marginal increase in bacteremic and fungal infections." @default.
• W1977393182 created "2016-06-24" @default.
• W1977393182 creator A5024171763 @default.
• W1977393182 creator A5034364750 @default.
• W1977393182 creator A5053095799 @default.
• W1977393182 creator A5060218087 @default.
• W1977393182 creator A5088417730 @default.
• W1977393182 date "1994-07-01" @default.
• W1977393182 modified "2023-10-17" @default.
• W1977393182 title "Acute myeloid leukemia in manitoba" @default.
• W1977393182 cites W118967028 @default.
• W1977393182 cites W1255825804 @default.
• W1977393182 cites W1481564836 @default.
• W1977393182 cites W1521735444 @default.
• W1977393182 cites W1555330200 @default.
• W1977393182 cites W1586763410 @default.
• W1977393182 cites W1823520599 @default.
• W1977393182 cites W1861929829 @default.
• W1977393182 cites W1881046587 @default.
• W1977393182 cites W1912991550 @default.
• W1977393182 cites W1919339218 @default.
• W1977393182 cites W1929561528 @default.
• W1977393182 cites W1933669930 @default.
• W1977393182 cites W1988104415 @default.
• W1977393182 cites W2028844198 @default.
• W1977393182 cites W2054034736 @default.
• W1977393182 cites W2076426515 @default.
• W1977393182 cites W2088211388 @default.
• W1977393182 cites W2088520561 @default.
• W1977393182 cites W2089038077 @default.
• W1977393182 cites W2142097265 @default.
• W1977393182 cites W2150113701 @default.
• W1977393182 cites W2242156109 @default.
• W1977393182 cites W2252759819 @default.
• W1977393182 cites W2260141671 @default.
• W1977393182 cites W2294319072 @default.
• W1977393182 cites W2335721167 @default.
• W1977393182 cites W2414191600 @default.
• W1977393182 cites W330020766 @default.
• W1977393182 cites W4236309725 @default.
• W1977393182 cites W4237543851 @default.
• W1977393182 cites W4237785786 @default.
• W1977393182 cites W4239564692 @default.
• W1977393182 cites W4242394811 @default.
• W1977393182 cites W4253716544 @default.
• W1977393182 cites W4293241248 @default.
• W1977393182 doi "https://doi.org/10.1002/1097-0142(19940701)74:1<52::aid-cncr2820740110>3.0.co;2-g" @default.
• W1977393182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8004583" @default.
• W1977393182 hasPublicationYear "1994" @default.
• W1977393182 type Work @default.
• W1977393182 sameAs 1977393182 @default.
• W1977393182 citedByCount "20" @default.
• W1977393182 countsByYear W19773931822013 @default.
• W1977393182 countsByYear W19773931822014 @default.
• W1977393182 countsByYear W19773931822015 @default.
• W1977393182 countsByYear W19773931822016 @default.
• W1977393182 countsByYear W19773931822018 @default.
• W1977393182 crossrefType "journal-article" @default.
• W1977393182 hasAuthorship W1977393182A5024171763 @default.
• W1977393182 hasAuthorship W1977393182A5034364750 @default.
• W1977393182 hasAuthorship W1977393182A5053095799 @default.
• W1977393182 hasAuthorship W1977393182A5060218087 @default.
• W1977393182 hasAuthorship W1977393182A5088417730 @default.
• W1977393182 hasBestOaLocation W19773931821 @default.
• W1977393182 hasConcept C126322002 @default.
• W1977393182 hasConcept C141071460 @default.
• W1977393182 hasConcept C2776611710 @default.
• W1977393182 hasConcept C2776694085 @default.
• W1977393182 hasConcept C2777063308 @default.
• W1977393182 hasConcept C2778041864 @default.
• W1977393182 hasConcept C2778461978 @default.
• W1977393182 hasConcept C2778729363 @default.
• W1977393182 hasConcept C2778850193 @default.
• W1977393182 hasConcept C2781021840 @default.
• W1977393182 hasConcept C2781413609 @default.
• W1977393182 hasConcept C2991767035 @default.
• W1977393182 hasConcept C38180746 @default.
• W1977393182 hasConcept C71924100 @default.
• W1977393182 hasConcept C90924648 @default.
• W1977393182 hasConceptScore W1977393182C126322002 @default.
• W1977393182 hasConceptScore W1977393182C141071460 @default.
• W1977393182 hasConceptScore W1977393182C2776611710 @default.
• W1977393182 hasConceptScore W1977393182C2776694085 @default.
• W1977393182 hasConceptScore W1977393182C2777063308 @default.
• W1977393182 hasConceptScore W1977393182C2778041864 @default.
• W1977393182 hasConceptScore W1977393182C2778461978 @default.
• W1977393182 hasConceptScore W1977393182C2778729363 @default.
• W1977393182 hasConceptScore W1977393182C2778850193 @default.
• W1977393182 hasConceptScore W1977393182C2781021840 @default.
• W1977393182 hasConceptScore W1977393182C2781413609 @default.
• W1977393182 hasConceptScore W1977393182C2991767035 @default.
• W1977393182 hasConceptScore W1977393182C38180746 @default.
• W1977393182 hasConceptScore W1977393182C71924100 @default.
• W1977393182 hasConceptScore W1977393182C90924648 @default.
• W1977393182 hasIssue "1" @default.
• W1977393182 hasLocation W19773931821 @default.
• W1977393182 hasLocation W19773931822 @default.
• W1977393182 hasOpenAccess W1977393182 @default.

• next